TED Ted Baker Plc

RNS Number:2876W
Tepnel Life Sciences PLC
23 May 2002

For Further Information:

Tepnel Life Sciences                                              0161 946 2200
Ben Matzilevich, CEO
Gron Ffoulkes-Davies, Finance Director

HCC De Facto Group                                                020 7496 3300
David Dible / Mark Swallow

Tepnel Life Sciences ('Tepnel') Signs First European Distribution Agreement For
Its T1000 Automated DNA Purification System

Cogerdis SA to Distribute T1000 in France

Manchester, UK. 23 May 2002...Tepnel Life Sciences PLC (AIM: TED) is pleased to
announce today that it has signed its first European distribution agreement for
its recently introduced T1000 Automated DNA Purification System. The agreement
with French company Cogerdis SA covers the marketing in France of the T1000,
associated consumables and Tepnel's Nucleon manual DNA purification products and
future systems for the purification of genomic DNA.

Under the terms of this multiple year distribution agreement, Cogerdis, a
specialist distributor of biomedical instruments and reagents, will immediately
purchase a number of T1000 systems and has committed to on-going purchases for
additional instruments.

The T1000, which was launched in December 2001, is Tepnel's first automated
system for plasmid DNA purification. This cost-effective, dedicated system,
which is specifically designed for academic laboratories and research
laboratories within pharmaceutical and biotechnology industries combines
ease-of-use with complete automation and excellent performance, and generates
high-quality DNA suitable for automated DNA sequencing systems.

Commenting on the announcement, Ben Matzilevich, Tepnel's CEO, said: "The French
biomedical research market has grown tremendously in the past few years and we
are very pleased to have teamed up with Cogerdis to distribute our T1000 in this
important region. Discussions are ongoing with other European and US
distributors and we are confident that we will be able to announce additional
distribution partners over the next few months."

                                     -ends-



Notes to Editors

Tepnel Life Sciences is a global biotechnology company with a "tripolar"
strategy focused on providing the biomedical industry with high-throughput
automated DNA purification systems, manual DNA purification kits and reagents,
as well as scientific services for nucleic acid purification, drug analysis,
genotyping and genetically modified foods (GMOs).

The Company was founded in 1992 to exploit DNA technology generated at UMIST
(University of Manchester Institute of Science and Technology) and is listed on
the AIM segment of the London Stock Exchange (AIM: TED).

www.tepnel.com



                      This information is provided by RNS
            The company news service from the London Stock Exchange

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024